Journal article
Mothers after Gestational Diabetes in Australia (MAGDA): A Randomised Controlled Trial of a Postnatal Diabetes Prevention Program
SL O’Reilly, JA Dunbar, V Versace, E Janus, JD Best, R Carter, JJN Oats, T Skinner, M Ackland, PA Phillips, PR Ebeling, J Reynolds, STF Shih, V Hagger, M Coates, C Wildey
Plos Medicine | PUBLIC LIBRARY SCIENCE | Published : 2016
Abstract
Background: Gestational diabetes mellitus (GDM) is an increasingly prevalent risk factor for type 2 diabetes. We evaluated the effectiveness of a group-based lifestyle modification program in mothers with prior GDM within their first postnatal year. Methods and Findings: In this study, 573 women were randomised to either the intervention (n = 284) or usual care (n = 289). At baseline, 10% had impaired glucose tolerance and 2% impaired fasting glucose. The diabetes prevention intervention comprised one individual session, five group sessions, and two telephone sessions. Primary outcomes were changes in diabetes risk factors (weight, waist circumference, and fasting blood glucose), and seconda..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
The National Health and Medical Research Council funded the study under their Partnership Projects scheme (AppID: 533956; https://www.nhmrc.gov.au/grants-funding/apply-funding/partnershipsbetter-health/partnerships-projects). The organisations that contributed funding to the MAGDA partnership were the NHMRC, the Victorian Department of Health, SA Health, and Diabetes Victoria Ltd. The NHMRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. As the funding was provided through the NHMRC Partnerships for Health funding round, co-funders/partners were required to provide funding and in-kind contributions, as well as release of key personnel for investigators' responsibilities on the trial (contributors are listed in the Acknowledgements).